Company · CIK 0000784199 · SIC 3841 — Surgical & Medical Instruments & Apparatus · NYSE
ARTIVION, INC. · AORT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2016 AForm 4 → | May 25, 4:38 pm EDT | Harvey MorganDirector | 8,734 | — | — | 52,336 | — | plan? |
| May 23, 2016 AForm 4 → | May 25, 4:36 pm EDT | Ronald D McCallDirector | 8,734 | — | — | 166,248 | — | plan? |
| May 23, 2016 AForm 4 → | May 25, 4:35 pm EDT | C Elkins RonaldDirector | 8,734 | — | — | 105,586 | — | plan? |
| May 23, 2016 AForm 4 → | May 25, 4:34 pm EDT | Daniel J BevevinoDirector | 8,734 | — | — | 94,086 | — | plan? |
| May 23, 2016 AForm 4 → | May 25, 4:33 pm EDT | James BensonDirector | 8,734 | — | — | 74,086 | — | plan? |
| May 23, 2016 AForm 4 → | May 25, 4:32 pm EDT | Thomas F AckermanDirector | 8,734 | — | — | 94,086 | — | plan? |
| May 10, 2016 SForm 4 → | May 12, 4:31 pm EDT | James BensonDirector | 5,000 | $12.22 | $61,100 | 65,352 | −7.11% | plan? |
| Apr 15, 2016 SForm 4 → | Apr 19, 4:29 pm EDT | C Elkins RonaldDirector | 1,000 | $12.00 | $12,000 | 96,852 | −1.02% | plan? |
| Mar 7, 2016 SForm 4 → | Mar 9, 8:10 am EST | C Elkins RonaldDirector | 2,000 | $11.18 | $22,360 | 97,852 | −2.00% | plan? |
| Mar 3, 2016 PForm 4 → | Mar 4, 5:20 pm EST | James P MackinPresident & CEO | 10,000 | $10.91 | $109,130 | 368,533 | +2.79% | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 4:41 pm EST | David C GaleVP, Research & Development | 416 | $10.54 | $4,385 | 71,606 | — | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 4:39 pm EST | David Ashley LeeExecutive VP, COO & CFO | 694 | $10.54 | $7,315 | 272,612 | — | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 4:37 pm EST | Amy HortonVP, Chief Accounting Officer | 277 | $10.54 | $2,920 | 85,322 | — | plan? |
| Feb 26, 2016 FForm 4 → | Mar 1, 4:34 pm EST | Scott B CappsVP, Clinical Research | 416 | $10.54 | $4,385 | 99,427 | — | plan? |
| Feb 19, 2016 AForm 4/A → | Sep 6, 2017, 5:40 pm EDT | James P MackinPresident & CEO | 42,484 | — | — | 323,316 | — | plan? |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:47 pm EST | Sherry M SauriniVP, Quality | 5,294 | $10.24 | $54,211 | 5,294 | — | plan? |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:45 pm EST | William Robert MatthewsSenior VP, Operations, Quality | 9,314 | $10.24 | $95,375 | 17,814 | — | plan? |
| Feb 19, 2016 AFForm 4 → | Feb 23, 5:44 pm EST | James P MackinPresident & CEO | 88,995 | $10.24 | $503,101 | 358,533 | — | plan? amended |
| Feb 19, 2016 AFForm 4 → | Feb 23, 5:43 pm EST | David Ashley LeeExecutive VP, COO & CFO | 35,338 | $10.29 | $199,453 | 273,306 | — | plan? |
| Feb 19, 2016 AFForm 4 → | Feb 23, 5:41 pm EST | Amy HortonVP, Chief Accounting Officer | 14,794 | $10.24 | $86,180 | 85,599 | — | plan? |
| Feb 19, 2016 AFForm 4 → | Feb 23, 5:39 pm EST | Jean F HollowayVP, General Counsel | 23,141 | $10.29 | $141,657 | 34,351 | — | plan? |
| Feb 19, 2016 AFForm 4 → | Feb 23, 5:37 pm EST | David C GaleVP, Research & Development | 18,511 | $10.24 | $91,617 | 69,575 | — | plan? |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:36 pm EST | John E DavisSenior VP, Global Sales | 9,314 | $10.24 | $95,375 | 19,314 | — | plan? |
| Feb 19, 2016 SForm 4 → | Feb 23, 5:35 pm EST | Scott B CappsVP, Clinical Research | 15,000 | $10.30 | $154,500 | 91,873 | −14.0% | plan? |
| Feb 19, 2016 AFMForm 4 → | Feb 23, 5:35 pm EST | Scott B CappsVP, Clinical Research | 33,511 | $6.85 | $164,067 | 99,843 | — | plan? |
| Feb 18, 2016 SForm 4 → | Feb 19, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 8,000 | $10.13 | $81,040 | 243,284 | −3.18% | plan? |
| Feb 17, 2016 FMForm 4 → | Feb 19, 4:36 pm EST | Amy HortonVP, Chief Accounting Officer | 13,261 | $6.56 | $86,932 | 72,931 | — | plan? |
| Feb 17, 2016 FMForm 4 → | Feb 19, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 26,712 | $6.04 | $161,303 | 251,284 | — | plan? |
| Feb 12, 2016 FForm 4 → | Feb 16, 4:38 pm EST | David Ashley LeeExecutive VP, COO & CFO | 7,173 | $9.06 | $64,987 | 236,296 | — | plan? |
| Feb 12, 2016 FForm 4 → | Feb 16, 4:36 pm EST | Amy HortonVP, Chief Accounting Officer | 2,868 | $9.06 | $25,984 | 68,192 | — | plan? |
| Feb 12, 2016 FForm 4 → | Feb 16, 4:35 pm EST | Scott B CappsVP, Clinical Research | 4,232 | $9.06 | $38,342 | 84,520 | — | plan? |
| Feb 12, 2016 FForm 4 → | Feb 16, 4:33 pm EST | David C GaleVP, Research & Development | 4,225 | $9.06 | $38,279 | 54,252 | — | plan? |
| Dec 28, 2015 SForm 4 → | Dec 30, 3:25 pm EST | David Ashley LeeExec. VP, COO and CFO | 700 | $11.00 | $7,700 | 243,969 | −0.29% | plan? |
| Dec 28, 2015 MForm 4 → | Dec 30, 3:25 pm EST | David Ashley LeeExec. VP, COO and CFO | 1,000 | $4.83 | $4,830 | 244,269 | — | plan? |
| Nov 27, 2015 SForm 4 → | Dec 1, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 11,800 | $11.03 | $130,148 | 239,969 | −4.69% | plan? |
| Nov 27, 2015 MForm 4 → | Dec 1, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,800 | $4.83 | $76,314 | 243,969 | — | plan? |
| Oct 22, 2015 GForm 4 → | Oct 23, 8:27 am EDT | Harvey MorganDirector | 10,000 | — | — | 33,000 | — | plan? |
| Sep 15, 2015 SForm 4 → | Sep 17, 8:32 am EDT | James BensonDirector | 5,839 | $9.65 | $56,346 | 70,352 | −7.66% | plan? |
| Sep 11, 2015 SForm 4/A → | Sep 15, 4:34 pm EDT | James BensonDirector | 4,161 | $9.65 | $40,154 | 76,191 | −5.18% | plan? |
| Sep 11, 2015 SForm 4 → | Sep 14, 4:41 pm EDT | James BensonDirector | 3,359 | $9.65 | $32,414 | 76,993 | −4.18% | plan? |
| Sep 10, 2015 AForm 4 → | Sep 17, 8:30 am EDT | John E DavisSenior VP, Global Sales | 10,000 | — | — | 10,000 | — | plan? late |
| Sep 10, 2015 AForm 4 → | Sep 15, 7:02 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,500 | — | — | 8,500 | — | plan? late amended |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:50 pm EDT | Jean F HollowayVP, General Counsel | 7,252 | — | — | 14,252 | — | plan? amended |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:41 pm EDT | James BensonDirector | 10,352 | — | — | 80,352 | — | plan? |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:39 pm EDT | Harvey MorganDirector | 10,352 | — | — | 48,602 | — | plan? |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:37 pm EDT | Ronald D McCallDirector | 10,352 | — | — | 157,514 | — | plan? |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:36 pm EDT | Jon W SalvesonDirector | 10,352 | — | — | 65,352 | — | plan? |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:34 pm EDT | C Elkins RonaldDirector | 10,352 | — | — | 99,852 | — | plan? |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:33 pm EDT | Daniel J BevevinoDirector | 10,352 | — | — | 85,352 | — | plan? |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:32 pm EDT | Thomas F AckermanDirector | 10,352 | — | — | 85,352 | — | plan? |
| Jun 2, 2015 GForm 4 → | Jun 4, 8:34 am EDT | David Ashley LeeExecutive VP, COO & CFO | 250 | — | — | 239,969 | — | plan? |
| Apr 9, 2015 FForm 4/A → | Apr 15, 5:01 pm EDT | Steven G AndersonFormer Executive Chairman | 44,404 | $10.18 | $452,033 | 1,271,846 | — | plan? |
| Apr 9, 2015 FForm 4 → | Apr 13, 5:30 pm EDT | Steven G AndersonFormer Executive Chairman | 57,681 | $10.18 | $587,193 | 1,258,569 | — | plan? amended |
| Apr 1, 2015 AForm 4 → | Apr 2, 5:00 pm EDT | Jean F HollowayVP, General Counsel | 7,000 | — | — | 7,000 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:54 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 1,739 | $10.51 | $18,277 | 239,719 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:53 pm EDT | Amy HortonChief Accounting Officer | 507 | $10.51 | $5,329 | 71,060 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:47 pm EDT | David C GaleVP, Research & Development | 1,043 | $10.51 | $10,962 | 58,477 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:45 pm EDT | David FronkVP, Regulatory Affairs | 1,217 | $10.51 | $12,791 | 110,559 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:44 pm EDT | Scott B CappsVP, Clinical Research | 869 | $10.51 | $9,133 | 88,752 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:43 pm EDT | Steven G AndersonExecutive Chairman | 5,469 | $10.51 | $57,479 | 1,316,250 | — | plan? |
| Mar 7, 2015 FForm 4 → | Mar 10, 4:41 pm EDT | Bruce G. AndersonVP, US Sales &Global Marketing | 695 | $10.51 | $7,304 | 42,106 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 5:00 pm EST | David Ashley LeeExecutive VP, COO & CFO | 9,723 | $10.72 | $14,890 | 241,458 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 4:58 pm EST | Scott B CappsVP, Clinical Research | 5,833 | $10.72 | $8,930 | 89,621 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 4:56 pm EST | Steven G AndersonExecutive Chairman | 25,132 | $10.72 | $46,075 | 1,321,719 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 4:55 pm EST | David FronkVP, Regulatory Affairs | 6,806 | $10.72 | $10,420 | 111,776 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 4:53 pm EST | Amy HortonChief Accounting Officer | 3,874 | $10.72 | $5,789 | 71,567 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 4:51 pm EST | David C GaleVP, Research & Development | 5,833 | $10.72 | $8,930 | 59,520 | — | plan? |
| Feb 26, 2015 AForm 4 → | Feb 27, 4:49 pm EST | David P. LangVP, Int'l Sales & Marketing | 5,000 | — | — | 73,441 | — | plan? |
| Feb 26, 2015 AFForm 4 → | Feb 27, 4:47 pm EST | Bruce G. AndersonVP, US Sales &Global Marketing | 5,833 | $10.72 | $8,930 | 42,801 | — | plan? |
| Feb 23, 2015 FMForm 4 → | Feb 25, 8:36 am EST | Steven G AndersonExecutive Chairman | 122,993 | $10.09 | $1,240,562 | 1,305,183 | — | plan? |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:55 pm EST | James P MackinPresident & CEO | 30,832 | $11.00 | $339,152 | 280,832 | — | plan? |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:52 pm EST | David P. LangVP, Int'l Sales & Marketing | 7,399 | $11.00 | $81,389 | 68,441 | — | plan? |
| Feb 18, 2015 AFForm 4 → | Feb 20, 4:53 pm EST | David Ashley LeeExecutive VP, COO & CFO | 17,891 | $10.94 | $195,801 | 234,513 | — | plan? |
| Feb 18, 2015 AFForm 4 → | Feb 20, 4:50 pm EST | Amy HortonChief Accounting Officer | 6,785 | $10.95 | $74,302 | 68,773 | — | plan? |
| Feb 18, 2015 AFForm 4 → | Feb 20, 4:49 pm EST | David C GaleVP, Research & Development | 10,816 | $10.94 | $118,361 | 55,353 | — | plan? |
| Feb 18, 2015 AFForm 4 → | Feb 20, 4:47 pm EST | David FronkVP, Regulatory Affairs | 12,655 | $10.94 | $138,481 | 104,829 | — | plan? |
| Feb 18, 2015 AFForm 4 → | Feb 20, 4:46 pm EST | Scott B CappsVP, Clinical Research | 10,192 | $10.95 | $111,609 | 85,454 | — | plan? |
| Feb 18, 2015 FSForm 4 → | Feb 20, 4:45 pm EST | Steven G AndersonExecutive Chairman | 41,395 | $10.90 | $451,239 | 1,300,676 | — | plan? |
| Feb 18, 2015 AFForm 4 → | Feb 20, 4:43 pm EST | Bruce G. AndersonVP, US Sales &Global Marketing | 9,606 | $10.96 | $105,269 | 38,634 | — | plan? |
| Feb 16, 2015 FMForm 4 → | Feb 25, 8:33 am EST | David FronkVP, Regulatory Affairs | 27,915 | $10.46 | $291,890 | 106,914 | — | plan? late |
| Feb 12, 2015 FForm 4 → | Feb 13, 5:25 pm EST | Amy HortonChief Accounting Officer | 748 | $11.40 | $8,527 | 65,692 | — | plan? |
| Feb 12, 2015 FForm 4 → | Feb 13, 5:04 pm EST | Steven G AndersonChairman | 4,262 | $11.40 | $48,587 | 1,342,071 | — | plan? |
| Feb 12, 2015 FForm 4 → | Feb 13, 5:02 pm EST | David Ashley LeeExecutive VP, COO & CFO | 1,871 | $11.40 | $21,329 | 227,738 | — | plan? |
| Feb 12, 2015 FForm 4 → | Feb 13, 4:58 pm EST | Bruce G. AndersonVP, US Sales &Global Marketing | 1,122 | $11.40 | $12,791 | 33,442 | — | plan? |
| Feb 12, 2015 FForm 4 → | Feb 13, 4:56 pm EST | David FronkVP, Regulatory Affairs | 1,310 | $11.40 | $14,934 | 100,218 | — | plan? |
| Feb 12, 2015 FForm 4 → | Feb 13, 4:53 pm EST | David C GaleVP, Research & Development | 1,122 | $11.40 | $12,791 | 51,371 | — | plan? |
| Feb 12, 2015 FForm 4 → | Feb 13, 4:50 pm EST | Scott B CappsVP, Clinical Research | 1,122 | $11.40 | $12,791 | 80,848 | — | plan? |
| Jul 30, 2014 AForm 4/A → | Feb 20, 2015, 4:41 pm EST | Harvey MorganDirector | 10,000 | — | — | 38,250 | — | plan? |
| Nov 11, 2013 SForm 4/A → | Mar 1, 2016, 4:33 pm EST | David C GaleVP, Research & Development | 150 | $9.97 | $1,496 | 36,049 | −0.41% | plan? |
| Nov 8, 2013 FForm 4/A → | Mar 1, 2016, 4:33 pm EST | David C GaleVP, Research & Development | 100 | $9.90 | $990 | 36,199 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 MForm 4 → | Jun 15, 11:28 am EDT | Andrew M GreenSVP, Regulatory and Quality | 44,001 | — | — | 0 | — | 10b5-1 |
| Mar 6, 2019 MForm 4 → | Mar 8, 6:10 pm EST | Amy HortonVP, Chief Accounting Officer | 6,666 | $6.12 | $40,796 | 0 | — | |
| Mar 5, 2019 AForm 4 → | Mar 8, 10:23 am EST | Thomas J BogenschuetzVP, EMEA & General Manager | 12,787 | — | — | 12,787 | — | late |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:56 pm EST | Scott B CappsVP, Clinical Research | 7,265 | — | — | 7,265 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:55 pm EST | John E DavisSenior VP, Global Sales | 12,787 | — | — | 12,787 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:53 pm EST | Jean F HollowayVP, General Counsel | 12,787 | — | — | 12,787 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:52 pm EST | Amy HortonVP, Chief Accounting Officer | 7,992 | — | — | 7,992 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:51 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,257 | — | — | 15,257 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:49 pm EST | James P MackinPresident & CEO | 61,842 | — | — | 61,842 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:48 pm EST | Dennis B MaierVice President, Operations | 7,265 | — | — | 7,265 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:45 pm EST | James M McDermidSVP, CHRO | 11,625 | — | — | 11,625 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:43 pm EST | Michael S SimpsonSVP, Regulatory Affairs and QA | 11,625 | — | — | 11,625 | — | |
| Sep 18, 2018 MForm 4 → | Sep 20, 5:02 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 0 | — | |
| Aug 30, 2018 MForm 4 → | Sep 4, 6:59 pm EDT | Scott B CappsVP, Clinical Research | 8,332 | $5.67 | $47,242 | 0 | — | |
| Aug 15, 2018 MForm 4 → | Aug 16, 5:24 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 16,666 | $5.67 | $94,496 | 0 | — | |
| Aug 13, 2018 MForm 4 → | Aug 15, 5:48 pm EDT | James P MackinPresident & CEO | 150,000 | $10.24 | $1,536,000 | 16,265 | — | |
| Aug 10, 2018 MForm 4 → | Aug 13, 4:34 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 0 | — | |
| Aug 7, 2018 MForm 4 → | Aug 9, 5:27 pm EDT | Jean F HollowayVP, General Counsel | 4,000 | $10.28 | $41,120 | 1,500 | — | |
| Aug 7, 2018 JForm 4 → | Aug 9, 5:26 pm EDT | James P MackinPresident & CEO | 331,300 | — | — | 75,615 | — | |
| Jul 26, 2018 MForm 4 → | Jul 30, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 3,391 | $16.30 | $55,273 | 0 | — | |
| Jul 23, 2018 MForm 4 → | Jul 25, 4:44 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 5,500 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:48 am EST | Sherry M SauriniVP, Quality | 226 | $23.67 | $5,350 | 0 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:47 am EST | James M McDermidSVP, CHRO | 178 | $23.67 | $4,214 | 0 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:46 am EST | Jean F HollowayVP, General Counsel | 614 | $23.67 | $14,535 | 0 | — | |
| Jun 14, 2018 MForm 4 → | Jun 15, 5:19 pm EDT | John E DavisSenior VP, Global Sales | 4,372 | $10.24 | $44,769 | 8,745 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:23 pm EDT | Amy HortonVP, Chief Accounting Officer | 5,000 | $5.67 | $28,350 | 0 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:22 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 13,117 | — | |
| May 16, 2018 DForm 4 → | May 18, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $27.00 | $118,071 | 17,490 | — | |
| May 8, 2018 MForm 4 → | May 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 17,491 | — | |
| May 3, 2018 MForm 4 → | May 8, 4:24 pm EDT | John E DavisSenior VP, Global Sales | 3,334 | $9.64 | $32,140 | 3,333 | — | late |
| Apr 17, 2018 MForm 4 → | Apr 18, 4:42 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 6,667 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:52 pm EDT | James M McDermidSVP, CHRO | 15,910 | — | — | 15,910 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:51 pm EDT | James P MackinPresident & CEO | 77,562 | — | — | 77,562 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 21,877 | — | — | 21,877 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | Amy HortonVP, Chief Accounting Officer | 12,430 | — | — | 12,430 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:49 pm EDT | Jean F HollowayVP, General Counsel | 19,092 | — | — | 19,092 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:48 pm EDT | John E DavisSenior VP, Global Sales | 15,910 | — | — | 15,910 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:47 pm EDT | Scott B CappsVP, Clinical Research | 9,944 | — | — | 9,944 | — | |
| Feb 13, 2018 MForm 4 → | Feb 15, 5:28 pm EST | Scott B CappsVP, Clinical Research | 31,333 | $17.10 | $535,794 | 0 | — | |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:49 pm EDT | Sherry M SauriniVP, Quality | 382 | $16.24 | $6,202 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:47 pm EDT | James M McDermidSVP, CHRO | 2,358 | $16.24 | $38,282 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:46 pm EDT | Jean F HollowayVP, General Counsel | 1,722 | $16.24 | $27,957 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 6,007 | $16.27 | $97,744 | 16,953 | — | late |
| Dec 31, 2017 AMForm 5 → | Jan 25, 2018, 4:47 pm EST | James M McDermidSVP, CHRO | 1,642 | $16.28 | $26,728 | 0 | — | |
| Dec 31, 2017 AMForm 5 → | Jan 25, 2018, 4:46 pm EST | Jean F HollowayVP, General Counsel | 1,134 | $16.28 | $18,459 | 0 | — | |
| Nov 16, 2017 MForm 4 → | Nov 17, 4:17 pm EST | David C GaleVP, Research & Development | 20,000 | — | — | 0 | — | |
| Nov 8, 2017 MForm 4 → | Nov 13, 4:47 pm EST | David Ashley LeeExecutive VP, COO & CFO | 63,333 | $18.80 | $1,190,438 | 0 | — | late |
| Jun 27, 2017 MForm 4 → | Jun 29, 9:19 am EDT | Amy HortonVP, Chief Accounting Officer | 18,667 | — | — | 0 | — | |
| Feb 22, 2017 MForm 4 → | Feb 24, 9:10 am EST | Scott B CappsVP, Clinical Research | 16,667 | $16.40 | $273,360 | 0 | — | |
| Dec 31, 2016 AMForm 5 → | Jul 11, 2017, 8:56 am EDT | John E DavisSenior VP, Global Sales | 6,610 | — | — | 0 | — | |
| Sep 12, 2016 MForm 4 → | Sep 14, 5:30 pm EDT | Jean F HollowayVP, General Counsel | 3,000 | — | — | 3,000 | — | |
| Sep 12, 2016 MForm 4 → | Sep 14, 5:21 pm EDT | David C GaleVP, Research & Development | 3,000 | — | — | 3,000 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 6:07 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 33,333 | — | — | 1,500 | — | |
| Jul 26, 2016 MForm 4 → | Jul 28, 4:34 pm EDT | Amy HortonVP, Chief Accounting Officer | 10,000 | — | — | 0 | — | |
| Jun 30, 2016 AMForm 5 → | Jul 11, 2017, 8:58 am EDT | Jean F HollowayVP, General Counsel | 5,838 | — | — | 0 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:47 pm EST | Sherry M SauriniVP, Quality | 14,913 | — | — | 14,913 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:45 pm EST | William Robert MatthewsSenior VP, Operations, Quality | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:44 pm EST | James P MackinPresident & CEO | 119,672 | — | — | 119,672 | — | amended |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:43 pm EST | David Ashley LeeExecutive VP, COO & CFO | 36,822 | — | — | 36,822 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:41 pm EST | Amy HortonVP, Chief Accounting Officer | 20,713 | — | — | 20,713 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:39 pm EST | Jean F HollowayVP, General Counsel | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:37 pm EST | David C GaleVP, Research & Development | 20,713 | — | — | 20,713 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:36 pm EST | John E DavisSenior VP, Global Sales | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AMForm 4 → | Feb 23, 5:35 pm EST | Scott B CappsVP, Clinical Research | 35,713 | — | — | 418 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:36 pm EST | Amy HortonVP, Chief Accounting Officer | 9,000 | — | — | 9,000 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 20,700 | — | — | 8,000 | — | |
| Dec 28, 2015 MForm 4 → | Dec 30, 3:25 pm EST | David Ashley LeeExec. VP, COO and CFO | 1,000 | — | — | 8,200 | — | |
| Nov 27, 2015 MForm 4 → | Dec 1, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,800 | — | — | 8,500 | — | |
| Sep 10, 2015 AForm 4/A → | Sep 17, 8:36 am EDT | Jean F HollowayVP, General Counsel | 20,307 | — | — | 20,307 | — | |
| Sep 10, 2015 AForm 4/A → | Sep 17, 8:34 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,000 | — | — | 8,000 | — | |
| Sep 10, 2015 AForm 4 → | Sep 17, 8:30 am EDT | John E DavisSenior VP, Global Sales | 10,000 | — | — | 10,000 | — | late |
| Sep 10, 2015 AForm 4 → | Sep 15, 7:02 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,000 | — | — | 8,000 | — | late amended |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:50 pm EDT | Jean F HollowayVP, General Counsel | 20,307 | — | — | 20,307 | — | amended |
| Apr 1, 2015 AForm 4 → | Apr 2, 5:00 pm EDT | Jean F HollowayVP, General Counsel | 7,000 | — | — | 7,000 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 8:36 am EST | Steven G AndersonExecutive Chairman | 63,750 | — | — | 0 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:55 pm EST | James P MackinPresident & CEO | 85,105 | — | — | 85,105 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:53 pm EST | David Ashley LeeExecutive VP, COO & CFO | 34,042 | — | — | 34,042 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:52 pm EST | David P. LangVP, Int'l Sales & Marketing | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:50 pm EST | Amy HortonChief Accounting Officer | 13,617 | — | — | 13,617 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:49 pm EST | David C GaleVP, Research & Development | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:47 pm EST | David FronkVP, Regulatory Affairs | 23,829 | — | — | 23,829 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:46 pm EST | Scott B CappsVP, Clinical Research | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:43 pm EST | Bruce G. AndersonVP, US Sales &Global Marketing | 20,425 | — | — | 20,425 | — | |
| Feb 16, 2015 MForm 4 → | Feb 25, 8:33 am EST | David FronkVP, Regulatory Affairs | 15,000 | — | — | 0 | — | late |